Regulatory Beat

Sep 01, 2014
BioPharm International
FDA demands accurate manufacturing and test information to ensure product quality.
Sep 01, 2014
BioPharm International
As the pharmacovigilance infrastructure becomes more entrenched in Europe, drug manufacturers are beginning to feel the burden of its high cost.
Aug 01, 2014
BioPharm International
FDA seeks high quality applications and products to facilitate approvals and reduce safety and supply problems.
Jul 01, 2014
BioPharm International
Stakeholders face challenges and benefits from a more secure pharmaceutical supply chain.
May 02, 2014
The rising incidence of medicine defects and shortages stemming from sub-standard manufacturing is forcing Europe to give higher prominence to more effective inspections procedures.
May 01, 2014
BioPharm International
New formulations and expanded vaccine production are encouraged.
Apr 01, 2014
BioPharm International
As Europe strives to firmly incorporate quality-by-design principles, there are several key issues that still need to be addressed.
Apr 01, 2014
BioPharm International
New identifiers and tracking requirements aim to block illegitimate products.
Mar 01, 2014
BioPharm International
Manufacturers are taking measures to comply with new package safety rules.
Feb 01, 2014
BioPharm International
High technology assessments are having an impact on biosimilars development in Europe.
native1_300x100
lorem ipsum